← Open Payments lookup

PATRICIA MOORE: Open Payments

NPI 1871502112 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,341 in 116 payments from 21 companies in 2025. Trend: 2023 $2,696 · 2024 $2,469 · 2025 $2,341

Food & beverage: $2,341
CompanyPaymentsAmount
ABBVIE INC.33$529
Janssen Biotech, Inc.26$413
Ipsen Biopharmaceuticals, Inc5$199
Takeda Pharmaceuticals U.S.A., Inc.5$183
Lilly USA, LLC8$157
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$143
Celltrion USA Inc.5$116
Ardelyx, Inc.4$91
Gilead Sciences, Inc.4$84
Janssen Scientific Affairs, LLC1$62

Products named: TREMFYA, LINZESS, IQIRVO, RINVOQ, OMVOH, XIFAXAN, VEGZELMA, IBSRELA.

Industry payments across TX — which companies pay providers there.